The Effects of C-type Natriuretic Peptide on Human Forearm Blood Vessels
Not Applicable
Withdrawn
- Conditions
- Ischaemia-reperfusion (IR) Injury
- Interventions
- Registration Number
- NCT01075776
- Lead Sponsor
- Queen Mary University of London
- Brief Summary
To determine the effects of whether increasing CNP concentrations slightly above normal will improve the functioning of blood vessels after the interruption in the flow of blood. In this study we are looking at the function of the blood vessels of the forearm, as a substitute for those in the heart
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Healthy human volunteers on no systemic medication, excepting the oral contraceptive pill
Exclusion Criteria
- History of medical illness
- Unwillingness to sign consent form
- Use of non-OCP medications
- Hypertension on examination of the blood pressure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description CNP C-type natriuretic peptide (CNP) Infusion of CNP prior to IR injury Saline Saline Effect of saline infusion prior to IR injury CNP Acetylcholine Infusion of CNP prior to IR injury Saline Acetylcholine Effect of saline infusion prior to IR injury
- Primary Outcome Measures
Name Time Method Change in area under curve dose-response to acetylcholine after IR injury 2h
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does C-type Natriuretic Peptide (CNP) utilize to improve endothelial function in ischaemia-reperfusion injury?
How does CNP compare to standard vasodilators like nitrates or ACE inhibitors in treating IR injury in peripheral blood vessels?
Are there specific biomarkers that correlate with enhanced vascular response to CNP in forearm ischaemia models?
What adverse events are associated with CNP administration in human vascular studies and how are they managed?
What combination therapies involving CNP show promise in mitigating IR injury compared to monotherapy approaches?
Trial Locations
- Locations (1)
Queen Mary University London
🇬🇧London, United Kingdom
Queen Mary University London🇬🇧London, United Kingdom